Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 71
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Investig Clin Urol ; 64(1): 56-65, 2023 01.
Article in English | MEDLINE | ID: mdl-36629066

ABSTRACT

PURPOSE: The purpose of this study is to investigate disease trend of genital wart through changes in each treatment method over the past 10 years in Korea. MATERIALS AND METHODS: From 2010 to 2019, surgical treatment including cauterization, excision, cryotherapy, and laser therapy, non-surgical treatment such as podophyllin, and surgical treatment for anorectal lesion were extracted and analyzed from 2010 to 2019. For each treatment method, characteristics such as sex, age, region, medical cost and average number of procedures were analyzed. RESULTS: The number of patients following all treatment modalities increased every year. Surgical treatment of genital wart and anorectal wart showed a significant increase in male patients. Number of non-surgical treatment decreased in males but increased in females. Surgical removal of the anorectal wart increased more than 250% in over 10 years, and males underwent surgery 4 times more than females. In both surgery and non-surgery, the mean session was higher in males. Most of them were carried out in primary medical institutions. In Seoul and Gyeonggi-do, the largest number of patients received treatment regardless of treatment method. CONCLUSIONS: Treatment for genital warts has increased rapidly over the past 10 years, and the increase in males is remarkable. The main treatment was surgery, and males mainly received surgical treatment, and females mainly received drug treatment. The primary medical institution was in charge of the most treatment. As the number of patients and related medical expenses are increasing rapidly, more attention and response to diseases are needed.


Subject(s)
Condylomata Acuminata , Warts , Female , Humans , Male , Condylomata Acuminata/surgery , Condylomata Acuminata/drug therapy , Warts/drug therapy , Podophyllin/therapeutic use , Delivery of Health Care , Republic of Korea
3.
Medicine (Baltimore) ; 97(16): e0329, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29668581

ABSTRACT

INTRODUCTION: Here we present the case of a 56-year-old human immunodeficiency virus (HIV)-infected man with multiple anal condylomas and positivity for human papilloma virus (HPV) 18 on anal brushing. Biopsies of the anal mucosa led to the diagnosis of Bowen's disease and a subsequent pelvic magnetic resonance imaging (MRI) scan evidenced multiple reactive lymphoadenopathies and large intra-anal condylomas. The patient was treated with a complete excision of Bowen's lesion and with a 4 months course of supplementation with a high concentration multistrain probiotic formulation administered orally and by rectal instillation with the purpose to reduce local inflammation and to enhance local mucosal immunity. CONCLUSION: An MRI performed at the end of the supplementation period evidenced the clearance of the anal condylomas previously described and no evidence of residual lymphadenopathies. Trials are therefore required to confirm this therapeutic possibility and for a better understanding of the mechanisms by which this specific probiotic formulation interacts with local epithelium when administered by the anal route.


Subject(s)
Bowen's Disease , Condylomata Acuminata , Dissection/methods , HIV Infections/complications , Intestinal Mucosa/drug effects , Papillomaviridae/isolation & purification , Probiotics/administration & dosage , Administration, Oral , Administration, Rectal , Anal Canal/pathology , Anal Canal/surgery , Bowen's Disease/diagnosis , Bowen's Disease/surgery , Bowen's Disease/therapy , Bowen's Disease/virology , Condylomata Acuminata/diagnosis , Condylomata Acuminata/surgery , Condylomata Acuminata/therapy , Condylomata Acuminata/virology , Dietary Supplements , HIV Seropositivity/diagnosis , Humans , Male , Middle Aged , Treatment Outcome
4.
J Obstet Gynaecol Res ; 40(10): 2110-3, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25132143

ABSTRACT

AIM: Zinc sulfate is beneficial in the treatment of epithelial warts. We conducted this study to compare the efficacy of combination therapy of oral zinc sulfate with conventional treatments in the treatment of vulvar warts. MATERIAL AND METHODS: This study was a randomized controlled trial. The sample size was 42 in each group. Women aged 20-50 years were placed by the block randomized method into six groups: the podophyllin-, imiquimod- and cryotherapy-treated groups, and another three groups receiving 8-week combination therapy of 400 mg oral zinc sulfate with one of the above-mentioned treatments. Data were analyzed using anova and Fischer's exact test with spss16. RESULTS: A total of 228 patients were recruited and completed the study in six treatment groups. No significant difference was observed in the response to treatment among these groups. Relapse after 6 months was significantly higher in the podophyllin-, imiquimod- and cryotherapy-treated patients compared to patients receiving these treatments in combination with oral zinc sulfate (P<0.05). CONCLUSIONS: Combined therapy of oral zinc sulfate with conventional treatments of vulvar warts appears to reduce the relapse rate.


Subject(s)
Aminoquinolines/therapeutic use , Condylomata Acuminata/drug therapy , Cryosurgery , Podophyllin/therapeutic use , Vulvar Diseases/drug therapy , Zinc Sulfate/therapeutic use , Administration, Cutaneous , Administration, Oral , Adult , Aminoquinolines/administration & dosage , Aminoquinolines/adverse effects , Astringents/administration & dosage , Astringents/adverse effects , Astringents/therapeutic use , Combined Modality Therapy , Condylomata Acuminata/prevention & control , Condylomata Acuminata/surgery , Cryosurgery/adverse effects , Female , Humans , Imiquimod , Interferon Inducers/administration & dosage , Interferon Inducers/adverse effects , Interferon Inducers/therapeutic use , Iran , Keratolytic Agents/administration & dosage , Keratolytic Agents/adverse effects , Keratolytic Agents/therapeutic use , Middle Aged , Patient Dropouts , Podophyllin/administration & dosage , Podophyllin/adverse effects , Secondary Prevention , Skin Cream , Vulvar Diseases/prevention & control , Vulvar Diseases/surgery , Young Adult , Zinc Sulfate/administration & dosage , Zinc Sulfate/adverse effects
5.
Dis Colon Rectum ; 57(6): 752-61, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24807601

ABSTRACT

BACKGROUND: Men who have sex with men have increased prevalence of both human papillomavirus and anogenital condyloma. OBJECTIVE: Risk factors for multiple treatment and recurrence of anal condyloma were examined. DESIGN: This is a retrospective study of HIV-negative men who have sex with men who were treated for anal condyloma. SETTINGS: This study was conducted in a private surgical practice. PATIENTS: The patients were HIV-negative men who have sex with men, aged 18 years or older. INTERVENTION(S): Ablation with electrocautery or CO2 laser was performed, as well as excision and topical imiquimod condyloma treatment adjuvant. MAIN OUTCOME MEASURES: Primary clearance, defined as 4 months of condyloma-free survival posttreatment, and recurrence, defined as any anal condyloma diagnosis after primary clearance. RESULTS: Of 231 participants, 207 achieved primary clearance (median age, 32.0 years) and were followed (median, 18.2 months) after primary treatment. Most had intra-anal and perianal condyloma (56%), were treated with electrocautery ablation (79.2%), and required 1 treatment (range, 1-6) for clearance. There were 57 recurrences (median, 12 months). One-third each had minimal, moderate, or extensive disease. Forty-six percent of patients received imiquimod posttreatment adjuvant. High-grade dysplasia was found in 31% at presentation and 43% during follow-up. Factors associated with requiring multiple treatments for clearance were participants having moderate disease (adjusted odds ratio, 6.0 (1.7-21.4)) and receiving imiquimod adjuvant (adjusted odds ratio, 4.7 (2.0-10.6)). No single factor predicted recurrence, but those with moderate disease experienced recurrences significantly sooner (median, 25 months of follow-up). LIMITATIONS: This was a retrospective chart review, it was limited to a single practice, and it excluded those who did not achieve primary clearance. CONCLUSIONS: Most men who have sex with men have intra-anal and perianal condyloma and concomitant high-grade dysplasia is common. Most achieved clearance with 1 treatment. Having both intra-anal and perianal condyloma, increased severity of disease, and imiquimod adjuvant were significant predictors of requiring multiple treatments for clearance. No identified risk factors proved a significant predictor of recurrence.


Subject(s)
Anus Diseases/surgery , Condylomata Acuminata/surgery , Severity of Illness Index , Adjuvants, Immunologic/therapeutic use , Adult , Aged , Aminoquinolines/therapeutic use , Anus Diseases/drug therapy , Anus Diseases/pathology , Chemotherapy, Adjuvant , Condylomata Acuminata/drug therapy , Condylomata Acuminata/pathology , Disease-Free Survival , Electrocoagulation , HIV Seronegativity , Homosexuality, Male , Humans , Imiquimod , Lasers, Gas/therapeutic use , Male , Middle Aged , Recurrence , Retrospective Studies , Risk Factors , Young Adult
6.
Dermatol Online J ; 19(6): 18559, 2013 Jun 15.
Article in English | MEDLINE | ID: mdl-24011309

ABSTRACT

This review summarizes new treatments from the last seven years employed for the treatment of genital warts caused by human papillomavirus (HPV). Imquimod 3.75% is a new agent with fewer side effects and perhaps a better dosing schedule than imquimod 5%, but is not more effective. Sinecatechins/Polyphenon E 15%, a novel extract from green tea can be effective against genital warts but requires three times a day dosing and is not more effective than existing treatments; the treatment course is 12-16 weeks. Photodynamic therapy combined with other destructive modalities might increase the cure rate for genital warts. The quadrivalent vaccine against HPV 6, 11, 16, 18 is decreasing the incidence of warts in the western world but the evidence does not support vaccination as a treatment for those already infected by HPV. Hyperthermia and immunomodulators might be positive additions to the armamentarium of clinicians. In sum, there are new tools that physicians can use but none is really a great advance over what was available a decade ago.


Subject(s)
Condylomata Acuminata/therapy , Genital Diseases, Female/therapy , Genital Diseases, Male/therapy , Abnormalities, Drug-Induced/etiology , Adjuvants, Immunologic/therapeutic use , Administration, Cutaneous , Aminoquinolines/administration & dosage , Aminoquinolines/adverse effects , Aminoquinolines/therapeutic use , Animals , Carcinogenicity Tests , Catechin/administration & dosage , Catechin/adverse effects , Catechin/analogs & derivatives , Catechin/therapeutic use , Clinical Trials as Topic , Condylomata Acuminata/drug therapy , Condylomata Acuminata/epidemiology , Condylomata Acuminata/prevention & control , Condylomata Acuminata/surgery , Dermatologic Agents/administration & dosage , Dermatologic Agents/adverse effects , Dermatologic Agents/therapeutic use , Electrocoagulation , Female , Genital Diseases, Female/drug therapy , Genital Diseases, Female/epidemiology , Genital Diseases, Female/prevention & control , Genital Diseases, Female/surgery , Genital Diseases, Male/drug therapy , Genital Diseases, Male/epidemiology , Genital Diseases, Male/prevention & control , Genital Diseases, Male/surgery , Glycyrrhizic Acid/administration & dosage , Glycyrrhizic Acid/therapeutic use , Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 , Humans , Hyperthermia, Induced , Imiquimod , Immunotherapy , Incidence , Male , Mice , Mice, Transgenic , Papillomavirus Vaccines , Photochemotherapy , Phytotherapy , Prevalence , Secondary Prevention , United States/epidemiology
7.
Am Fam Physician ; 86(12): 1118-24, 2012 Dec 15.
Article in English | MEDLINE | ID: mdl-23316984

ABSTRACT

Cutaneous cryosurgery refers to localized application of freezing temperatures to achieve destruction of skin lesions. It can be used to treat a broad range of benign and premalignant skin conditions, and certain malignant skin conditions, with high cure rates. Cellular destruction is accomplished by delivery of the cryogen via dipstick, probe, or spray techniques. It is widely used in primary care because of its safety, effectiveness, low cost, ease of use, good cosmetic results, and lack of need for anesthesia. Cryosurgery is as effective as alternative therapies for most cases of molluscum contagiosum, dermatofibromas, keloids, and plantar or genital warts. It is a more effective cure for common warts than salicylic acid or observation. Cryosurgery is generally the treatment of choice for actinic keratosis. Contraindications to cryosurgery include cryofibrinogenemia, cryoglobulinemia, Raynaud disease, agammaglobulinemia, and multiple myeloma. Complications from cryosurgery include hypopigmentation and alopecia, and can be avoided by limiting freeze times to less than 30 seconds. Referral to a dermatologist should be considered in cases of diagnostic uncertainty or for treatment of skin cancer, which requires larger amounts of tissue destruction, resulting in higher complication rates.


Subject(s)
Cryosurgery/methods , Skin Diseases/surgery , Condylomata Acuminata/surgery , Cryosurgery/adverse effects , Cryosurgery/economics , Cryosurgery/instrumentation , Histiocytoma, Benign Fibrous/surgery , Humans , Keloid/surgery , Keratosis, Actinic/surgery , Molluscum Contagiosum/surgery , Practice Guidelines as Topic , Skin Diseases/pathology , Skin Neoplasms/surgery , Treatment Outcome , United States , Warts/surgery , Wound Healing
8.
Akush Ginekol (Sofiia) ; 50(4): 45-51, 2011.
Article in Bulgarian | MEDLINE | ID: mdl-22479897

ABSTRACT

The treatment of Condylomata acuminata often causes disappointment to both the physician and the patient since most of the current medical approaches require multiple examines while on the other hand success rates are low and recurrence rates remain high. The treatment approaches include surgical as well as non-surgical methods. The non-surgical treatment includes the application of local agents such as imiquimod, podophyllotoxin, and 5-fluorouracil. Other local agents, used in outpatient treatment settings, include trichloroacetic acid (TCA), podophyllin, or the intralesional application of agents such as interferon and bleomycin. The surgical methods include cryotherapy, electrosurgery, excision and laser therapy. Their major goal is the removal of the visible lesions. The development of the laser systems and the new HPV vaccines are a significant progress in the treatment and prevention of the HPV infections.


Subject(s)
Condylomata Acuminata/therapy , Genital Diseases, Female/therapy , Alphapapillomavirus/isolation & purification , Aminoquinolines/therapeutic use , Antimetabolites/therapeutic use , Caustics/therapeutic use , Condylomata Acuminata/diagnosis , Condylomata Acuminata/drug therapy , Condylomata Acuminata/surgery , Cryotherapy , Electrosurgery , Female , Fluorouracil/therapeutic use , Genital Diseases, Female/diagnosis , Genital Diseases, Female/drug therapy , Genital Diseases, Female/surgery , Humans , Imiquimod , Interferon Inducers/therapeutic use , Podophyllin/therapeutic use , Trichloroacetic Acid/therapeutic use
9.
J Med Life ; 3(3): 286-8, 2010.
Article in English | MEDLINE | ID: mdl-20945819

ABSTRACT

This is a prospective study to assess a complementary treatment for genital warts after laser vaporization. 62 patients were enrolled in two randomized groups: Al: laser vaporization alone. A2: laser vaporization, followed with Pidotimod plus vitamin C for 2 1/2 months. The latter treatment shortened the time of warts remission and marginally decreased the rate of the warts' recurrence: 81% versus 67% (N.S.). Despite the non-significant difference, this complementary treatment seems to have some efficiency.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Ascorbic Acid/administration & dosage , Condylomata Acuminata/drug therapy , Condylomata Acuminata/surgery , Laser Therapy , Pyrrolidonecarboxylic Acid/analogs & derivatives , Thiazolidines/administration & dosage , Administration, Oral , Adolescent , Adult , Combined Modality Therapy , Condylomata Acuminata/immunology , Female , Humans , Prospective Studies , Pyrrolidonecarboxylic Acid/administration & dosage , Young Adult
10.
Colorectal Dis ; 12(8): 799-803, 2010 Aug.
Article in English | MEDLINE | ID: mdl-19548899

ABSTRACT

AIM: Human papillomavirus is the most common cause of sexually transmitted disease. It is associated with immunosuppression and shows a marked tendency to recur. We investigated a natural immunostimulant aimed to reduce recurrence. METHOD: A randomized controlled study was carried out including 261 patients allocated to surgical excision alone (control group; n = 122) and surgical excision plus postoperative immunostimulation for 30 days with a natural product (STET; study group; n = 139). Patients with HIV positivity were excluded. All patients gave fully informed consent. RESULTS: The patients were followed for 6 months after surgery. Recurrence occurred in 7.2% (10/139) in the study group and in 27.1% (33/122) in the control group (P < 0.0001). There were no significant differences in the sex, sexual orientation, number of lesions, time to diagnosis and treatment or localization of lesions in the two groups. CONCLUSIONS: Immunostimulation using a natural product significantly reduced the incidence of recurrence of anal condylomata in patients undergoing surgical excision.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Anus Diseases/surgery , Anus Diseases/therapy , Condylomata Acuminata/surgery , Condylomata Acuminata/therapy , Plant Preparations/therapeutic use , Adolescent , Adult , Andrographis , Anus Diseases/virology , Carica , Child , Citrus paradisi , Echinacea , Female , Humans , Male , Middle Aged , Phytotherapy/methods , Prospective Studies , Secondary Prevention , Statistics, Nonparametric , Tabebuia , Uncaria , Young Adult
11.
Rev. argent. coloproctología ; 19(1): 45-46, mar. 2008. ilus
Article in Spanish | LILACS | ID: lil-574125

ABSTRACT

Las verrugas perianales son producidas por el papiloma virus. Los tipos asociados son 6, 11 y 18. Comunicamos nuestra experiencia en el tratamiento de una paciente de 42 años con un condiloma perianal gigante.


Condylomas of genital warts are caused by the papiloma virus. Is produced by type 6, 11 and 18. We communicate our experience in the treatment of giant condylomatosis in a woman of 42 years old.


Subject(s)
Humans , Adult , Female , Condylomata Acuminata/surgery , Condylomata Acuminata/etiology , Condylomata Acuminata/mortality , Condylomata Acuminata/therapy , Administration, Topical , Colostomy , Interferon-alpha , Papillomavirus Infections/complications , Podophyllin/therapeutic use
12.
Int J STD AIDS ; 18(8): 531-7, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17686214

ABSTRACT

To determine whether an educational event can affect treatment choice for ano-genital warts, genitourinary medicine clinicians attending a wart management lecture were shown 14 photographs of genital warts of differing morphology at different sites and asked to choose their preferred method of treatment. Study questionnaires were completed pre-lecture and repeated after the lecture and discussion. Podophyllin was chosen significantly less frequently and cryotherapy more frequently post-lecture for certain wart types. Podophyllotoxin was favoured for multiple small penile and posterior fourchette warts, whereas imiquimod was chosen predominantly for large or bulky lesions. Trichloracetic acid was infrequently chosen as a treatment option (<6% of respondents). This study has shown that clinicians attending a lecture on the management of ano-genital warts do change their treatment choice for certain clinical scenarios. Whether opting for a particular treatment in a lecture setting translates to altered practice in the clinical setting requires further study.


Subject(s)
Condylomata Acuminata , Education, Medical, Continuing/methods , Inservice Training/methods , Practice Patterns, Physicians' , Condylomata Acuminata/drug therapy , Condylomata Acuminata/surgery , Cryosurgery/statistics & numerical data , Female , Humans , Keratolytic Agents/therapeutic use , Male , Physicians , Podophyllin/therapeutic use , Podophyllotoxin/therapeutic use
13.
Surgeon ; 4(6): 378-83, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17152203

ABSTRACT

BACKGROUND: The Buschke-Löwenstein tumour (BLT) or giant condyloma acuminata is a rare disease which affects the anogenital region. Although histologically benign, it behaves in a malignant fashion, infiltrating the surrounding tissues. The morbidity and mortality from this tumour is high, as is the risk of recurrence following treatment. It lies on the continuum between the benign condylomata acuminata and squamous cell carcinoma. The human papillomavirus is implicated in its aetiology. Treatment is controversial, with topical chemotherapy, radiotherapy, immunotherapy and radical surgery all having been employed. Chemoradiation remains the mainstay of treatment for anal cancers but has not been routinely employed in the management of the BLT without squamous cell carcinoma transformation. METHODS: Two cases of extensive perineal BLT treated with chemoradiation and subsequent surgical excision are presented. RESULTS: The first patient had a good symptomatic response to the chemoradiation but unfortunately died of recurrent disease following surgery. The second patient had a macroscopically complete response to chemoradiation and remains well following abdominoperineal excision. CONCLUSION: Pre-operative chemoradiation has proved to be useful in management for histologically proven benign BLT


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Condylomata Acuminata/therapy , Neoadjuvant Therapy , Perineum/pathology , Perineum/surgery , Soft Tissue Neoplasms/therapy , Abdominal Neoplasms/secondary , Abdominal Neoplasms/therapy , Adult , Anus Neoplasms/secondary , Anus Neoplasms/therapy , Carcinoma in Situ/pathology , Carcinoma in Situ/therapy , Carcinoma, Squamous Cell/therapy , Chemotherapy, Adjuvant , Cisplatin/administration & dosage , Condylomata Acuminata/drug therapy , Condylomata Acuminata/pathology , Condylomata Acuminata/radiotherapy , Condylomata Acuminata/surgery , Fatal Outcome , Fluorouracil/administration & dosage , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Radiotherapy, Adjuvant , Rectal Neoplasms/secondary , Rectal Neoplasms/therapy , Soft Tissue Neoplasms/drug therapy , Soft Tissue Neoplasms/pathology , Soft Tissue Neoplasms/radiotherapy , Soft Tissue Neoplasms/surgery
14.
J Pediatr Surg ; 40(9): e25-7, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16150329

ABSTRACT

Buschke-Löwenstein tumor or giant condyloma is a warty verrucous lesion, characterized by slow growth, locally infiltrating and disfiguring lesions. Despite its benign histological appearance and low risk of metastasis, Buschke-Löwenstein tumor is an intermediate lesion between condyloma acuminatum and verrucous carcinoma. It has been linked to human papilloma virus, mainly subtypes 6 and 11. Other factors implicated in this disease include poor hygiene, chronic irritation, promiscuity, and cellular immunocompromised states. It rarely occurs in children. The first line of treatment is radical surgical excision with or without adjuvant chemotherapy. We report the case of a 12-year-old girl with a giant perianal condyloma that was treated with surgical excision and a 6-week course of 5-fluorouracil beginning 6 weeks after surgery, with excellent functional and cosmetic results.


Subject(s)
Anus Neoplasms/drug therapy , Carcinoma, Verrucous/drug therapy , Condylomata Acuminata/drug therapy , Antimetabolites, Antineoplastic/therapeutic use , Anus Neoplasms/surgery , Carcinoma, Verrucous/surgery , Child , Condylomata Acuminata/surgery , Female , Fluorouracil/therapeutic use , Humans , Treatment Outcome
15.
Int J STD AIDS ; 16(3): 212-6, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15829021

ABSTRACT

This was a cross-sectional survey that collected data relating to management of anogenital warts (AGW) during a single-patient visit only at genitourinary medicine clinics. Single-agent use of cryotherapy, podophyllotoxin and trichloroacetic acid (TCA) were the most common treatment modalities, accounting for over two-thirds of all modalities used. Podophyllin, alone or in combination with other agents, was used for about 20% of first-line treatments. Podophyllin was included in about 15% of all treatment modalities. Guidelines for the management of AGW continue to recommend the use of podophyllin, but this may need to be modified in the light of recent publications. Podophyllin, TCA, podophyllotoxin or combinations of these agents are commonly used to treat keratinized warts. About 11% of all treatments involved a combination of two or more agents.


Subject(s)
Condylomata Acuminata/drug therapy , Condylomata Acuminata/surgery , Medical Audit , Cross-Sectional Studies , Cryosurgery , Female , Humans , Keratolytic Agents/therapeutic use , Male , Podophyllin/therapeutic use , Podophyllotoxin/therapeutic use , Practice Patterns, Physicians' , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/surgery , Trichloroacetic Acid/therapeutic use
17.
Zhonghua Er Bi Yan Hou Ke Za Zhi ; 38(6): 421-5, 2003 Dec.
Article in Chinese | MEDLINE | ID: mdl-15040102

ABSTRACT

OBJECTIVE: To evaluate some perplexing problems in the diagnosis and treatment of juvenil recurrent laryngeal papillomatosis (JRLP) and the relationship between juvenile onset recurrent respiratory papillomatosis(JORRP) and infantile laryngeal condyloma accuminatum (ILCA). METHODS: A group of 44 cases with JRLP were analyzed retrospectively from March, 1994 to March, 2002 in the light of literature review. RESULTS: The average age of first visit was 1.6 years. Average 5.3 operations had been performed per patient. There was an interval of average 2.4 months between two surgical excisions. Of 233 operations, the total incidence rate of all the complications was 3.9%. At present, the laryngeal lesion of 18 cases have withered away for over 1 year. 11 cases have being followed up. 10 cases have lost follow-up and 5 cases have died (11.4%). Combined laryngeal lesion excision with tracheotomy aiming at prolonging operative interval or Chinese traditional medicine has received more satisfactory effect than other therapies. There is an extensive similarity between JORRP and ILCA. CONCLUSIONS: To demondrate further whether JORRP and ILCA are the same identical disease has important significance in both theoretical study and clinic practice. The treatment for JRLP is still difficult. The tracheotomy for laryngeal obstruction resulted from the laryngeal lesion of JRLP should be avoided as far as possible. Combined laryngeal lesion excision with tracheotomy aiming at prolonging opertive interval or Chinese traditional medicine shows optimistic prospect.


Subject(s)
Condylomata Acuminata , Laryngeal Diseases , Laryngeal Neoplasms , Papilloma , Child , Child, Preschool , Condylomata Acuminata/diagnosis , Condylomata Acuminata/drug therapy , Condylomata Acuminata/surgery , Drugs, Chinese Herbal/therapeutic use , Female , Follow-Up Studies , Humans , Infant , Interferon Type I/therapeutic use , Laryngeal Diseases/diagnosis , Laryngeal Diseases/drug therapy , Laryngeal Diseases/surgery , Laryngeal Neoplasms/diagnosis , Laryngeal Neoplasms/drug therapy , Laryngeal Neoplasms/surgery , Male , Papilloma/diagnosis , Papilloma/drug therapy , Papilloma/surgery , Phytotherapy , Recurrence , Retrospective Studies
18.
Ann Dermatol Venereol ; 129(8-9): 991-6, 2002.
Article in French | MEDLINE | ID: mdl-12442095

ABSTRACT

OBJECTIVES: Condylomata acuminata (or genital warts) are sexually transmitted diseases caused by human papillomavirus. Until now, there has been no available epidemiologic data about this disease in France. We conducted a prospective study among French general practitioners (GPs) to estimate the incidence of consultations for external condylomata acuminata in general practice. We also assessed the management of patients with external condylomata acuminata by French GP's. DESIGN: A panel of French general practitioners, members of the Sentinel network, had to fill-in prospectively a questionnaire for each patient with condylomata acuminata diagnosed between July and November 2000. RESULTS: The annual number of consultations for external condylomata acuminata with French GP's was estimated at 23,000 (CI (95 p. 100) 21,000-25,000) including 15,000 new cases (CI (95 p. 100) 13,000-17,000). Taking into account the estimations we made at the same time in office-based private dermatologists, we estimated the annual incidence of external condylomata acuminata in France at 107/100 000 inhabitants. The management of patients with external condylomata acuminata by French GP's was in accordance with the European guidelines in 54 to 78 p. 100 of cases. French GP's mostly prescribed chemical treatment. DISCUSSION: A proportion of cases of condylomata acuminata may have not been diagnosed. Similarly, some lesions may have been wrongly diagnosed as condylomata acuminata, but these proportions of false positive and false negative remain unknown. The incidence of external condylomata acuminata in France is similar to those estimated in others developed countries.


Subject(s)
Condylomata Acuminata/epidemiology , Condylomata Acuminata/therapy , Penile Diseases/epidemiology , Penile Diseases/therapy , Vulvar Diseases/epidemiology , Vulvar Diseases/therapy , Adjuvants, Immunologic/therapeutic use , Adolescent , Adult , Aged , Aminoquinolines/therapeutic use , Cohort Studies , Condylomata Acuminata/drug therapy , Condylomata Acuminata/surgery , Family Practice , Female , France/epidemiology , Humans , Imiquimod , Interferon Inducers/therapeutic use , Keratolytic Agents/therapeutic use , Male , Middle Aged , Penile Diseases/drug therapy , Penile Diseases/surgery , Perineum , Podophyllin/therapeutic use , Podophyllotoxin/therapeutic use , Prospective Studies , Vulvar Diseases/drug therapy , Vulvar Diseases/surgery
19.
Ann Dermatol Venereol ; 129(8-9): 1013-22, 2002.
Article in French | MEDLINE | ID: mdl-12442099

ABSTRACT

External anogenital condylomas are the clinical expression of a human papillomavirus mucosal infection. However, only a small proportion of patients infected by this virus will express the disease. Nevertheless, this dermatitis remains one of the most prevalent of sexually transmitted diseases and poses problems in its management. These problems are centered on phenomena of viral latency, which do not permit one to guarantee the cure of the patient, and the absence of specific anti-viral treatment. This article proposes to review the status of external anogenital condylomas. Inspired by recently published experts' recommendations, it emphasizes the problems encountered in daily practice by proposing coherent practical approaches: better understanding of the disease and contamination, assessment of the lesions, the problems related to immunodepression, the psychological approach and current therapeutic possibilities.


Subject(s)
Condylomata Acuminata , Adjuvants, Immunologic/therapeutic use , Aminoquinolines/therapeutic use , Antiviral Agents/therapeutic use , Caustics/therapeutic use , Condylomata Acuminata/diagnosis , Condylomata Acuminata/drug therapy , Condylomata Acuminata/surgery , Cryosurgery , Female , Fluorouracil/therapeutic use , Humans , Imiquimod , Immunocompromised Host , Interferon Inducers/therapeutic use , Interferons/therapeutic use , Keratolytic Agents/therapeutic use , Laser Therapy , Male , Podophyllin/therapeutic use , Podophyllotoxin/therapeutic use , Sexual Partners , Trichloroacetic Acid/therapeutic use
20.
Clin Infect Dis ; 35(Suppl 2): S210-24, 2002 Oct 15.
Article in English | MEDLINE | ID: mdl-12353208

ABSTRACT

External genital warts (EGWs) are visible warts that occur in the perigenital and perianal regions. They are due primarily to non-oncogenic human papillomavirus (HPV) types, usually types 6 and 11. Physical examination assisted by bright light and magnification is the recommended approach for primary diagnosis. Biopsy is indicated when EGWs are fixed to underlying structures or discolored or when standard therapies are not effective. Recurrences are common, and there is no single treatment that is superior to others. Among women with atypical squamous cells, molecular HPV testing may be useful in determining who should be referred for colposcopy. Condoms may provide some protection against HPV-related diseases and thus are recommended in new sexual relationships and when partnerships are not mutually monogamous. Because the efficacy of cesarean section in preventing vertical transmission of HPV infection from women with EGWs to their progeny has not been proved, it is not recommended.


Subject(s)
Antineoplastic Agents/therapeutic use , Condylomata Acuminata/drug therapy , Papillomaviridae , Papillomavirus Infections/drug therapy , Tumor Virus Infections/drug therapy , Aminoquinolines/therapeutic use , Condylomata Acuminata/diagnosis , Condylomata Acuminata/surgery , Condylomata Acuminata/virology , Cryotherapy , Education , Electrosurgery , Female , Floxuridine/therapeutic use , Humans , Imiquimod , Interferons/therapeutic use , Laser Therapy , Male , Papillomavirus Infections/diagnosis , Papillomavirus Infections/surgery , Podophyllin/therapeutic use , Podophyllotoxin/therapeutic use , Tumor Virus Infections/diagnosis , Tumor Virus Infections/surgery
SELECTION OF CITATIONS
SEARCH DETAIL